Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Open Access
- 1 October 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (4), 1281-1291
- https://doi.org/10.1016/s0002-9440(10)65230-3
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Ligation of CD40 Activates Interleukin 1β-converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1βPublished by Elsevier ,1997
- The RXR heterodimers and orphan receptorsCell, 1995
- Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human MacrophagesBiochemical and Biophysical Research Communications, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Mutation of serine‐516 in human prostaglandin G/H synthase‐2 to methionine or aspirin acetylation of this residue stimulates 15‐R‐HETE synthesisFEBS Letters, 1994
- Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissuesFEBS Letters, 1993
- Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequenceFEBS Letters, 1988
- PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblastsBiochemical and Biophysical Research Communications, 1987
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984